Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanovex Biotechnologies
Llanera, Asturias, Spain
- Ownership
- Private
- Development stage
- Other
01
Overview
Nanovex Biotechnologies develops innovative drug delivery nanosystems, such as liposomes and nanoparticles, enhancing stability, bioavailability, and targeted delivery. Their systems have demonstrated significant efficacy improvements—including in skin penetration and dermal restoration—though they are primarily R&D and technology platform providers rather than developers of proprietary therapeutics
- Therapeutic areas
- ImmunologyInfectious DiseasesRare DiseasesDermatologyOncology
- Modalities
- NanoparticleLiposomeNanovesicleMetallic nanoparticlesSmall unilamellar vesiclesCationic liposomesNiosomeBiologicOligonucleotide
- Industry
- Drug Discovery Services
02
Partnerships
OLIGOFASTX consortium (with Sylentis/PharmaMar Group and other Spanish firms for oligonucleotide drug delivery)European Commission research grants
Beyond the preview
Go deeper on Nanovex Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nanovex Biotechnologies.